Search Results 1261-1270 of 13926 for Assay
The purpose of this study is train and test classifiers for lung cancer detection using the DELFI assay and other biomarker and clinical features. A Study ...
The details of the genotype assay methods must be recorded;; Patients without available local test results for HLA genotyping must submit a blood sample to ...
The purpose of this study is to validate the Alzheimer Disease Biomarkers assays (Phospho-Tau/Total-Tau/Ab42) being implemented at Mayo to compare them to the ...
Tumor PD-L1 status, confirmed by a reference laboratory using the Ventana SP263 PD-L1 immunohistochemistry (IHC) assay, must be known prior to randomization.
... assay are not eligible to participate unless they also have MMR testing by IHC and are found to have dMMR (i.e. loss of one or more MMR proteins); Patients ...
* Serum free light chain (FLC) assay: "involved" FLC level ≥ 10 mg/dL ( ≥ 100 mg/L) and an abnormal serum free light chain ratio ( \< 0.26 or \> 1.65) * ...
... assay; 4. Failed or been intolerant of prior lines of systemic therapy; 5. Estimated life expectancy > 4 months; 6. At least 1 measurable lesion per RECIST ...
Planned use of other commercially available or investigational cfDNA or gene expression profile assays for rejection surveillance. Pregnant. Hemodynamically ...
Qualifying deleterious SPOP mutation detected on any archival genomic assay (tissue and/or liquid biopsy) is acceptable for study inclusion. Qualifying ...
The purpose of this study is to validate the use of a RNAseq-based peripheral blood assay in liver transplant recipients when correlated to liver biopsy results ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.